OliX Pharmaceuticals올릭스
226950 · KOSDAQ · ₩226950 · 올릭스
₩96,500▼ ₩800 (0.82%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 14, 2026Open on DART
Predicted impact: Low· Actual: +0.7% vs sector, volume 0.9× normal (5 trading days)
- Major management matter relevant to investors투자판단관련주요경영사항 (임상시험계획 승인 신청 반려)Oct 12, 2026Open on DART
Predicted impact: Medium· Actual: −11.1% vs sector, volume 1.3× normal (5 trading days)
Regulator rejected clinical trial plan approval request; a setback for a pipeline program, size unknown.
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 안전성과 유효성을 평가하기 위한 다기관, 무작위 배정, 이중 눈가림, 위약 대조, 다중 상승 용량 제1b/2a상 임상시험 계획 승인)Oct 8, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Oct 6, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청)Sep 30, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청)Sep 16, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 안전성과 유효성을 평가하기 위한 다기관, 무작위 배정, 이중 눈가림, 위약 대조, 다중 상승 용량 제1b/2a상 임상시험 계획 승인신청)Sep 8, 2026Open on DART
- Exercise of Conversion Rights on Convertible Preferred Shares (Convertible Preferred Stock)전환주식의전환청구권행사 (전환우선주)Sep 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Sep 1, 2026Open on DART
- Exercise of Conversion Rights on Convertible Preferred Shares (Convertible Preferred Stock)전환주식의전환청구권행사 (전환우선주)Aug 31, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (Hansoh와의 공동연구 및 염기서열 이전 계약 체결)Aug 21, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Aug 12, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Aug 12, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Aug 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Aug 10, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (중추신경계 전달체 기술평가 및 기술도입 옵션 계약 체결)Aug 4, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Aug 3, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 30, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Jul 16, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Jul 16, 2026Open on DART
- Shareholders' meeting called주주총회소집결의 (임시주주총회)Jul 15, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jul 15, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Jul 15, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jul 15, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jul 8, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 7, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jun 29, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 29, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jun 29, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 15, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jun 1, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 1, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 1, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Audit report submitted감사보고서제출Mar 16, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 3, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: OliX Pharmaceuticals / 올릭스 / 226950 / KRX:226950
Source: KRX statistical information